Skip to main content
Clinical Trials/IRCT20191217045769N1
IRCT20191217045769N1
Recruiting
未知

A comparative study on the effect of using nasal protector (Neo-Guard)on the incidence rate and severity of nasal injury in preterm infants treated with Nasal-Continuous Positive Airway Pressure

Esfahan University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Premature infants 32 weeks or less or premature infants weighing 1500 g or less who require N\-CPAP
  • Parents are satisfied with the baby's entry into the study.

Exclusion Criteria

  • Premature infants who are \>32 weeks of postmenstrual age (PMA) or Premature infants(\<37 weeks(PMA)) at a weight \<1500 g
  • The infant was intubated before receiving N\-CPAP and received invasive ventilation
  • Preterm infants who had facial features that might preclude treatment with binasal CPAP (eg, cleft lip, Pierre Robin sequence,choanal atresia)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A comparison of the effect of Nasal Continuous Positive Airway Pressure (NCPAP) vs Nasal high-frequency oscillation(NHFO) in the treatment of respiratory distress in preterm infants
IRCT20201222049795N1Semnan University of Medical Sciences20
Completed
Not Applicable
Comparison of the effectiveness of nasal continuous positive airway pressure (NCPAP) therapy with combination of High-Frequency Oscillations and NCPAP in treatment of respiratory distress syndrome in infantsRespiratory distress syndrome.Respiratory distress syndrome of newbornP22.0
IRCT20180915041040N3Shahre-kord University of Medical Sciences40
Recruiting
Not Applicable
Evaluation of the Use of Antiseptic Nose For Decolonization of Resistant Bacteria in HospitalsHuman patients infectedMethicillin-resistant Staphylococcus aureus.B03.300.390.400.800.750.100.500
RBR-6gs2jhFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Completed
Not Applicable
study for the quantitative assessment of the nasal pathway as compared to combined oro-nasal pathway in terms of expired tidal volume when patient is ventilated via face mask under general anaesthesia.
CTRI/2019/02/017777Maulana Azad Medical college40
Completed
Phase 2
euroEPO in patients with Mild-Moderate Alzheimer's diseaseMild to moderate Alzheimer'sAlzheimer DiseaseDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders
RPCEC00000232Center of Molecular Immunology (CIM)174